2002
DOI: 10.1186/1471-2407-2-18
|View full text |Cite
|
Sign up to set email alerts
|

Decreased expression of the mannose 6- phosphate/insulin-like growth factor-II receptor promotes growth of human breast cancer cells

Abstract: Background: Loss or mutation of the mannose 6-phosphate/insulin-like growth factor-II receptor (M6P/IGF2R) has been found in breast cancer. However, whether or not decreased levels of functional M6P/IGF2R directly contribute to the process of carcinogenesis needs to be further verified by functional studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
41
1

Year Published

2003
2003
2014
2014

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 50 publications
(43 citation statements)
references
References 36 publications
1
41
1
Order By: Relevance
“…Our data support findings of IGF2R GSEs in proliferation screen (Primiano et al, 2003) and IGF2R antisense effect on survival of HSV1-infected cells (Zhou and Roizman, 2002). However, IGF2R role as a death receptor for granzyme B during cytotoxic T-cell-induced apoptosis (Motyka et al, 2000), apoptogenic effect of IGF2R overexpression in colon carcinoma SW48 cells (Souza et al, 1999) and cytoprotective effect of IGF2R ribozyme in MCF7 breast carcinoma cells (Chen et al, 2002) appear to be contradictory to our results. A recent study of IGF2R overexpression (Schaffer et al, 2003) reports opposing proliferation phenotypes in different prostate cancer cell lines offering potential explanation for such discrepancy.…”
Section: Discussioncontrasting
confidence: 56%
See 1 more Smart Citation
“…Our data support findings of IGF2R GSEs in proliferation screen (Primiano et al, 2003) and IGF2R antisense effect on survival of HSV1-infected cells (Zhou and Roizman, 2002). However, IGF2R role as a death receptor for granzyme B during cytotoxic T-cell-induced apoptosis (Motyka et al, 2000), apoptogenic effect of IGF2R overexpression in colon carcinoma SW48 cells (Souza et al, 1999) and cytoprotective effect of IGF2R ribozyme in MCF7 breast carcinoma cells (Chen et al, 2002) appear to be contradictory to our results. A recent study of IGF2R overexpression (Schaffer et al, 2003) reports opposing proliferation phenotypes in different prostate cancer cell lines offering potential explanation for such discrepancy.…”
Section: Discussioncontrasting
confidence: 56%
“…In total 25 genes in this category were identified by two or more putative GSEs (Table 1). We have included in the study the insulin-like growth factor II receptor/mannose-6-phosphate receptor (IGF2R) gene (which yielded a single antisense putative GSE in our apoptosis screen) since it was previously shown to promote apoptosis in different cancer cell models (Souza et al, 1999;Chen et al, 2002).…”
Section: Apoptogenic Gse Screen Hits Derived From the Genes Encoding mentioning
confidence: 99%
“…M6P/IGF2R is found inactivated in prostate cancer and the mutation of this gene is an early event in the development of prostate cancer (14). M6P/IGF2R also functions as a growth suppressor, but the loss or mutation of this gene contributes to development and progression of some cancers (15,16) and is involved in HBV-associated hepatocarcinogenesis (17). Moreover, M6P/ IGF2R controls cell adhesion and invasion by regulating αv integrin expression and accelerating uPAR cleavage (18), and restricts the metastatic propensity of squamous cell carcinomas (19).…”
Section: Introductionmentioning
confidence: 99%
“…Reduced expression of the receptor produced by various antisense strategies has the opposite effect of increasing cell proliferation and, in some case, reducing apoptosis. Reduced expression was reported to increase growth of JEG-3 cells in vitro and in vivo (O'Gorman et al, 1999) and enhance IGF-IIinduced proliferation and reduce susceptibility to TNFinduced apoptosis in the MCF-7 cells (Chen et al, 2002). While these studies provide information concerning possible roles of the receptor in the development of cancer, they have been carried out using cells with normal levels of the receptor that have acquired tumorigenic and metastatic characteristics through mechanisms other than those involving Man-6-P/IGF-2 expression.…”
Section: Introductionmentioning
confidence: 99%